Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News VIVESTO ADR OASMY

Vivesto AB, formerly Oasmia Pharmaceutical AB is a Swecen-based pharma company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company has a growing portfolio of projects in the clinical phase focused on advanced cancer. Apealea (paclitaxel micellar) is being developed for patients with ovarian cancer through a partnership with Elevar Therapeutics,... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (GREY:OASMY)

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Oasmia Pharmaceutical AB To Contact The Firm

Press Releases August 21, 2019

Oasmia Pharmaceutical AB (OASM), Eagle Bancorp, Inc. (EGBN) & 3M Company (MMM) - Bronstein, Gewirtz & Grossman, LLC - Class Action Reminder

Press Releases August 21, 2019

OASMIA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Oasmia Pharmaceutical AB To Contact The Firm

GlobeNewswire August 21, 2019

OASM CLASS ACTION DEADLINE: Hagens Berman Reminds Investors in Oasmia Pharmaceutical AB (OASM) of Upcoming Lead Plaintiff Deadline

Press Releases August 20, 2019

OASM LOSS NOTICE: ROSEN, A LEADING LAW FIRM, Reminds Oasmia Pharmaceutical AB Investors of Important September 27th Deadline in Securities Class Action - OASM

GlobeNewswire August 20, 2019

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Oasmia Pharmaceutical AB and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire August 20, 2019

Oasmia Pharmaceutical AB (OASM), Eagle Bancorp, Inc. (EGBN) & 3M Company (MMM) - Bronstein, Gewirtz & Grossman, LLC - Class Action Update

Press Releases August 19, 2019

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mallinckrodt, Oasmia Pharmaceutical, Aclaris Therapeutics, and Curaleaf and Encourages Investors to Contact the Firm

GlobeNewswire August 18, 2019

OASM NOTICE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM: Reminds Oasmia Pharmaceutical AB Investors of Important Deadline in Securities Class Action First Filed by the Firm- OASM

Press Releases August 18, 2019

Opinion & Analysis (GREY:OASMY)

No current opinion is available.

Bullboard Posts (GREY:OASMY)